Priority Date: 23.04.10 (DE 20101018961)

GENETICALLY MODIFIED SENDAI VIRUS FOR TREATMENT OF TUMOURS

  • Application ID: EP11718679
  • Status: EXAMINATION IN PROGRESS

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 11 - 50 employees
Company dna witte weller and partner
operating since 1987
Headquarter in Stuttgart
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 231 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 23.04.2010 - Priority Date (DE 20101018961)
  • 27.10.2011 - Publication A1 (WO2011131703)
  • 27.02.2013 - Publication A1 (EP2560986)

IPC Classification